The use of aztreonam in pediatric patients: a review
- PMID: 1902290
The use of aztreonam in pediatric patients: a review
Abstract
Aztreonam is the first monobactam available for use in this country. A parenteral antibiotic, its antibacterial spectrum is limited to gram-negative aerobic pathogens. The drug's pharmacologic, pharmacokinetic, and toxicologic properties are reviewed. Based on early experience in pediatric patients, certain recommendations can be made for the use of aztreonam.
Similar articles
-
Aztreonam: review of the clinical experience and potential uses in pediatrics.Pediatr Infect Dis J. 1988 May;7(5):331-9. Pediatr Infect Dis J. 1988. PMID: 3288947 Review. No abstract available.
-
Role of aztreonam in lower respiratory tract infections.Urology. 1988 Jun;31(6 Suppl):33-6. Urology. 1988. PMID: 3287748 Review.
-
[Aztreonam. A small-spectrum antibiotic in gram-negative infections].Tidsskr Nor Laegeforen. 1991 Aug 10;111(18):2277-8. Tidsskr Nor Laegeforen. 1991. PMID: 1896987 Norwegian. No abstract available.
-
Aztreonam in the treatment of serious gram-negative infections in the elderly.Int J Clin Pharmacol Ther Toxicol. 1988 Jan;26(1):22-6. Int J Clin Pharmacol Ther Toxicol. 1988. PMID: 3403089
-
[Aztreonam: monocenter microbiological study with prevention experience in surgery].G Batteriol Virol Immunol. 1987 Jan-Dec;80(1-12):237-51. G Batteriol Virol Immunol. 1987. PMID: 3509031 Italian.
Cited by
-
Antibacterial-induced nephrotoxicity in the newborn.Drug Saf. 1999 Mar;20(3):245-67. doi: 10.2165/00002018-199920030-00005. Drug Saf. 1999. PMID: 10221854 Review.
-
Antibiotics in neonatal infections: a review.Drugs. 1999 Sep;58(3):405-27. doi: 10.2165/00003495-199958030-00003. Drugs. 1999. PMID: 10493270 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical